Report overview
Buerger's disease is a rare disease of the arteries and veins in the arms and legs. It is also called as thromboangiitis obliterans. In Buerger's disease, the blood vessels become inflamed, swell, and get blocked due to blood clots.
This report aims to provide a comprehensive presentation of the global market for Buerger Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buerger Disease Diagnosis. This report contains market size and forecasts of Buerger Disease Diagnosis in global, including the following market information:
Global Buerger Disease Diagnosis Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Buerger Disease Diagnosis market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Blood Tests Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Buerger Disease Diagnosis include FUJIFILM Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., Pluristem Therapeutics Inc., Shimadzu Corporation, Siemens Healthcare GmbH, Stempeutics Research Pvt. Ltd., Canon Medical Systems Corporation and t2cure GmbH, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Buerger Disease Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Buerger Disease Diagnosis Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Buerger Disease Diagnosis Market Segment Percentages, by Type, 2023 (%)
Blood Tests
The Allen?s Test
Angiogram
Tissue Biopsy
Others
Global Buerger Disease Diagnosis Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Buerger Disease Diagnosis Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Medical Research Centers
Academic Institutes
Others
Global Buerger Disease Diagnosis Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Buerger Disease Diagnosis Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Buerger Disease Diagnosis revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Buerger Disease Diagnosis revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
FUJIFILM Holdings Corporation
GE Healthcare
Koninklijke Philips N.V.
Pluristem Therapeutics Inc.
Shimadzu Corporation
Siemens Healthcare GmbH
Stempeutics Research Pvt. Ltd.
Canon Medical Systems Corporation
t2cure GmbH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Buerger Disease Diagnosis, market overview.
Chapter 2: Global Buerger Disease Diagnosis market size in revenue.
Chapter 3: Detailed analysis of Buerger Disease Diagnosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Buerger Disease Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
